| Gene symbol | tk |
| GTO ID | GTC2585 |
| Trial ID | NCT04739046 |
| Disease | Pancreatic Cancer |
| Altered gene | yCD|tk |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | DNA oncolytic virus |
| Treatment | Theragene |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | A Single Arm, Open, Exploratory Clinical Trial to Evaluate Efficacy and Safety for Combination Treatment of Replication Competent Adenovirus Double Suicide Gene Therapy(Theragene, Ad5-yCD/mutTKSR39rep-ADP) and Radiation Therapy in Patients |
| Year | 2021 |
| Country | Korea,Republic of |
| Company sponsor | Seoul National University Bundang Hospital |
| Other ID(s) | SNUBH-IMGPB-2021-02 |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||